Business

March 5, 2014

Pozen reports narrower loss in fourth quarter

Pozen reported a narrower net loss in the fourth quarter thanks to revenue from its arthritis drug and the licensing of its its experimental cardiovascular treatment.

Related content

Comments

Editor's Choice Videos